52

Medinova Diagnostic Services LtdBOM 526301 Stock Report

Last reporting period 31 Mar, 2024

Updated 06 Nov, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

526301.BO Stock Analysis

52

Neutral

Based on Eyestock quantitative analysis, 526301.BO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

55/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-19.0 %

Overvalued

Market cap $B

0.002

Dividend yield

Shares outstanding

9.98 B

Medinova Diagnostic Services Ltd. is engaged in the business of medical or clinical services. The company is headquartered in Hyderabad, Telangana. The firm is engaged in providing a range of diagnostic services spanning pathological investigations, radiology and imaging, conventional, specialized lab services and diagnostic cardiology. The company offers various services ranging from an ordinary blood test to a computerized tomography (CT)/ magnetic resonance imaging (MRI) scan. Its investigations are classified are lab, radiology, imageology, cardiology and gastroscopy. The company has built up various profiles to meet various requirements of patients, such as Master Health Check Up, Executive Health Check Up, Well Woman Check Up, Cardiac Profile and Diabetic Profile. The company has designed various health schemes and packages to provide concessional treatment. Its services also include corporate services, home visits, ambulance services and health camps. Its diagnostic centers are set up under the franchise arrangement.

View Section: Eyestock Rating